Karen Krasney - Dec 13, 2024 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Signature
/s/ Linda Marban, Attorney-in-Fact
Stock symbol
CAPR
Transactions as of
Dec 13, 2024
Transactions value $
$11,120
Form type
4
Date filed
12/16/2024, 09:25 AM
Previous filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAPR Common Stock Options Exercise $11.1K +8K +39.91% $1.39 28K Dec 13, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAPR Stock Option (Right to Buy) Options Exercise $0 -3K -100% $0.00 0 Dec 13, 2024 Common Stock 3K $1.39 Direct F1, F2
transaction CAPR Stock Option (Right to Buy) Options Exercise $0 -5K -100% $0.00 0 Dec 13, 2024 Common Stock 5K $1.39 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 3, 2015 and was previously covering 30,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
F2 Shares vested 1/48th on the first day of each month commencing April 1, 2015.
F3 This option was granted on June 2, 2016 and was previously covering 50,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
F4 Shares vested 1/48th on the first day of each month commencing July 1, 2016.